Potentially ‘life changing’ arthritis drug listed on PBS Tofacitinib will be listed despite lingering concerns related to an increased risk of blood clots and potentially death when taken in high doses.
Safety concerns over popular arthritis drug The TGA issued an alert after a study found high doses of tofacitinib could lead to increased risk of blood clots in the lungs and potentially death.